Stay updated on Durvalumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.

Latest updates to the Durvalumab in Cervical Cancer Clinical Trial page
- ChecktodayChange DetectedReplaced the India location entry Gurgaon, 122001 with Gūrgaon, 122001 to standardize spelling, and updated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check7 days agoChange DetectedAdds Gurgaon, India, 122001 as a study location, replacing the previous Gūrgaon spelling variant; this expands recruitment options and standardizes the location data.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedMinor site version update from v3.4.1 to v3.4.2 with no changes to study content or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedUpdated the location name from Gurgaon, India, 122001 to Gūrgaon, India, 122001 with a diacritic.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page shows a new Revision: v3.3.4 and a deletion of Revision: v3.3.3, indicating a minor site version update with no changes to study content or functionality.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded a Locations section with multiple sites (Arizona, California, Florida, Georgia, Michigan, New York, Ohio, Tennessee, Texas, Gurgaon, India 122001) and removed the prior state locations; Revision updated to v3.3.3.SummaryDifference0.5%

Stay in the know with updates to Durvalumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.